Lambert Eaton Myasthenic Syndrome (LEMS)

Also known as: Eaton-Lambert Myasthenic Syndrome / Lambert Eaton Myasthenic Syndrome / Lambert-Eaton Myasthenic Syndrome (LEMS) / Lambert-Eaton Myasthenic Syndrome / Lambert-Eaton syndrome in neoplastic disease / Lambert-Eaton syndrome, unspecified / Eaton-Lambert syndrome (disorder) / Eaton-Lambert syndrome / Myasthenic syndrome

DrugDrug NameDrug Description
DB11640AmifampridineA voltage gated potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome.
DB00536GuanidineA strong organic base used to treat muscle weakness and fatigue associated with the myasthenic complications of Eaton-Lambert syndrome.
DrugDrug NamePhaseStatusCount
DB13906Aloe vera leaf2Active Not Recruiting1
DB11640Amifampridine2Completed1
DB09312Antilymphocyte immunoglobulin (horse)2Active Not Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Active Not Recruiting1
DB00126Ascorbic acid2Active Not Recruiting1
DB02379Beta-D-Glucose2Active Not Recruiting1
DB00262Carmustine2Active Not Recruiting1
DB14681Cortisone2Active Not Recruiting1
DB00987Cytarabine2Active Not Recruiting1
DB00773Etoposide2Active Not Recruiting1
DB09462Glycerin2Active Not Recruiting1
DB00888Mechlorethamine2Active Not Recruiting1
DB00959Methylprednisolone2Active Not Recruiting1
DB02701Nicotinamide2Active Not Recruiting1
DB00635Prednisone2Active Not Recruiting1
DB00162Vitamin A2Active Not Recruiting1
DB11640Amifampridine3Completed2
DB11640AmifampridineNot AvailableApproved for Marketing1
DB11640AmifampridineNot AvailableCompleted1
DB11640AmifampridineNot AvailableNo Longer Available6